Diazepam Injection — Class II drug recall D-1369-2012
Terminated recall by Meridian Medical Technologies a Pfizer Company, reported 2012-06-20, distributed nationwide. Impurities/Degradation Products: High Out of Specification levels for carbostyril, a known degradation product
| Recall number | D-1369-2012 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Meridian Medical Technologies a Pfizer Company, Saint Louis, MO, United States |
| Recall initiated | 2012-06-06 |
| Classified | 2012-06-11 |
| Reported by FDA | 2012-06-20 |
| Terminated | 2013-08-05 |
| Distributed | Nationwide (US) |
| Countries outside the US | CA, IT, SE, SG |
| Quantity | 83,400 autoinjectors |
| Reason classes | specification failure |
| NDC | 11704-0600, 11704-0600-01 |
| Lot numbers | 01/13, 03/13, 8D1082, 8D1151 |
Product
Diazepam Injection, USP, 10 mg Automatic, Autoinjector for Buddy Use, 5 mg/mL, 2 mL autoinjector, 15-count autoinjectors per carton, Rx only, Meridian Medical Technologies, Columbia, MD 21046; A subsidiary of King Pharmaceuticals, Inc.; NSN 6505-01-274-0951, NDC 11704-600-01.
Reason for recall
Impurities/Degradation Products: High Out of Specification levels for carbostyril, a known degradation product of diazepam.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1369-2012. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.